Product Name: CP-868596 (Crenolanib) | PDGFR inhibitor
Product Description: CP868596 (Crenolanib) is an orally-available, benzimidazole-based inhibitor of PDGFRa and PDGFRb with IC50 values of 0.9 and 1.8 nM, respectively. Furthermore, CP868596 is active against the D842V mutant of PDGFRa, inhibiting phosphorylation at an IC50 raWeb Site：Medchemexpress
Chemical Formula: C26H29N5O2
Molecular Weight: 443.54
‘&“CAS NO: 953769-46-5 BLZ945
Purity: 98%
Appearance: White
Chemical Name: 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-aminemGluR inhibitors
Solubility: Up to 100 mM in DMSO
Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage Condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.PubMed ID:http://www.springerlink.com/content/7248g65mvwp1xg56/
